Complete inhibition of vascular endothelial growth factor (VEGF) activities with a bifunctional diabody directed against both VEGF kinase receptors, fms-like tyrosine kinase receptor and kinase insert domain-containing receptor.
Dan Lu(Chinese Academy of Sciences), Zhenping Zhu(Double Helix (United States)), Peter Böhlen(La Roche College), Xenia Jimenez, Yan Wu(Central South University), Hongtao Zhang(Chinese Academy of Sciences), Luc de Witte(The Hague University of Applied Sciences)
PubMed
October 1, 2001
Cited by 49
Related Papers
Fluorescamine: A Reagent for Assay of Amino Acids, Peptides, Proteins, and Primary Amines in the Picomole Range
|Science|1972|2.7k
Fluorometric assay of proteins in the nanogram range
|Archives of Biochemistry and Biophysics|1973|1.6k
National Survey of Drug-Resistant Tuberculosis in China
|New England Journal of Medicine|2012|649
ErbB receptors: from oncogenes to targeted cancer therapies
|Journal of Clinical Investigation|2007|578
Advances in clinical immunotherapy for gastric cancer
|Biochimica et Biophysica Acta (BBA) - Reviews on Cancer|2021|435